Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
236 | 3 | PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL | 47933 |
282 | 2 | PROSTATE CANCER//PROSTATE//ANDROGEN RECEPTOR | 19095 |
2434 | 1 | CASTRATION RESISTANT PROSTATE CANCER//ENZALUTAMIDE//ABIRATERONE | 2282 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CASTRATION RESISTANT PROSTATE CANCER | authKW | 2478239 | 15% | 53% | 336 |
2 | ENZALUTAMIDE | authKW | 2353979 | 9% | 85% | 201 |
3 | ABIRATERONE | authKW | 2317142 | 9% | 84% | 199 |
4 | ABIRATERONE ACETATE | authKW | 1653823 | 6% | 85% | 141 |
5 | CABAZITAXEL | authKW | 1614146 | 7% | 73% | 160 |
6 | METASTATIC CASTRATION RESISTANT PROSTATE CANCER | authKW | 1047790 | 4% | 78% | 97 |
7 | CASTRATION RESISTANT | authKW | 637976 | 4% | 57% | 81 |
8 | CRPC | authKW | 422257 | 3% | 53% | 58 |
9 | MDV3100 | authKW | 362570 | 1% | 82% | 32 |
10 | ORTERONEL | authKW | 347132 | 1% | 93% | 27 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 26352 | 55% | 0% | 1266 |
2 | Urology & Nephrology | 24951 | 31% | 0% | 698 |
3 | Andrology | 583 | 1% | 0% | 24 |
4 | Endocrinology & Metabolism | 540 | 7% | 0% | 162 |
5 | Pharmacology & Pharmacy | 347 | 10% | 0% | 222 |
6 | Chemistry, Medicinal | 38 | 2% | 0% | 46 |
7 | Cell Biology | 34 | 4% | 0% | 96 |
8 | Health Care Sciences & Services | 26 | 1% | 0% | 27 |
9 | Medicine, General & Internal | 25 | 3% | 0% | 77 |
10 | Health Policy & Services | 22 | 1% | 0% | 18 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROSTATE CANC TARGETED THER Y GRP | 228271 | 1% | 72% | 23 |
2 | CAROLINA UROL | 79890 | 0% | 64% | 9 |
3 | GUSTAVE ROUSSY | 79212 | 3% | 8% | 74 |
4 | LANK GENITOURINARY ONCOL | 73214 | 1% | 17% | 32 |
5 | GENITOURINARY MED ONCOL PROGRAM | 71017 | 0% | 86% | 6 |
6 | GENITOURINARY ONCOL SERV | 63124 | 2% | 10% | 44 |
7 | UROL | 60661 | 31% | 1% | 713 |
8 | DRUG DEV UNIT | 52739 | 1% | 13% | 29 |
9 | VANCOUVER PROSTATE | 47859 | 2% | 10% | 35 |
10 | PROSTATE TARGETED THER Y GRP | 41428 | 0% | 100% | 3 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLINICAL GENITOURINARY CANCER | 67507 | 3% | 8% | 62 |
2 | PROSTATE | 19929 | 4% | 2% | 82 |
3 | EUROPEAN UROLOGY | 13532 | 4% | 1% | 85 |
4 | PROSTATE CANCER AND PROSTATIC DISEASES | 13221 | 1% | 3% | 33 |
5 | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 10920 | 2% | 2% | 40 |
6 | HORMONES & CANCER | 8201 | 0% | 6% | 10 |
7 | BJU INTERNATIONAL | 6788 | 3% | 1% | 64 |
8 | UROLOGE | 6462 | 1% | 2% | 30 |
9 | FUTURE ONCOLOGY | 6347 | 1% | 2% | 27 |
10 | LANCET ONCOLOGY | 6295 | 1% | 2% | 30 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CASTRATION RESISTANT PROSTATE CANCER | 2478239 | 15% | 53% | 336 | Search CASTRATION+RESISTANT+PROSTATE+CANCER | Search CASTRATION+RESISTANT+PROSTATE+CANCER |
2 | ENZALUTAMIDE | 2353979 | 9% | 85% | 201 | Search ENZALUTAMIDE | Search ENZALUTAMIDE |
3 | ABIRATERONE | 2317142 | 9% | 84% | 199 | Search ABIRATERONE | Search ABIRATERONE |
4 | ABIRATERONE ACETATE | 1653823 | 6% | 85% | 141 | Search ABIRATERONE+ACETATE | Search ABIRATERONE+ACETATE |
5 | CABAZITAXEL | 1614146 | 7% | 73% | 160 | Search CABAZITAXEL | Search CABAZITAXEL |
6 | METASTATIC CASTRATION RESISTANT PROSTATE CANCER | 1047790 | 4% | 78% | 97 | Search METASTATIC+CASTRATION+RESISTANT+PROSTATE+CANCER | Search METASTATIC+CASTRATION+RESISTANT+PROSTATE+CANCER |
7 | CASTRATION RESISTANT | 637976 | 4% | 57% | 81 | Search CASTRATION+RESISTANT | Search CASTRATION+RESISTANT |
8 | CRPC | 422257 | 3% | 53% | 58 | Search CRPC | Search CRPC |
9 | MDV3100 | 362570 | 1% | 82% | 32 | Search MDV3100 | Search MDV3100 |
10 | ORTERONEL | 347132 | 1% | 93% | 27 | Search ORTERONEL | Search ORTERONEL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |